Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Liver Neoplasms × perflutren × Clear all

Phase

Status

Completed 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2 Thyroid Neoplasms 1 Sleep Apnea, Obstructive 1 Rhinitis, Allergic, Seasonal 1 Pulmonary Fibrosis 1 Pulmonary Embolism 1 Pulmonary Disease, Chronic Obstructive 1 Mesothelioma 1 Lung Neoplasms 1 Lung Diseases, Interstitial 1 Liver Neoplasms 1 Hypertension, Pulmonary 1 Emphysema 1 Cystic Fibrosis 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Bronchiectasis 1 Asthma 1 Asbestosis 1

Interventions

Sorafenib 11 Radiosurgery 5 Capecitabine 5 Gemcitabine 4 Doxorubicin 4 Radiotherapy 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Fluorouracil 3 seocalcitol 2 regorafenib 2 phosphomannopentaose sulfate 2 atezolizumab 2 Thiotepa 2 Sunitinib 2 Radiofrequency Ablation 2 Oxaliplatin 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Fluorodeoxyglucose F18 2 Filgrastim 2 Dexamethasone 2 Chemoembolization, Therapeutic 2 Busulfan 2 Brachytherapy 2 Bevacizumab 2 voxilaprevir 1 vofatamab 1 velpatasvir 1 veliparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00955097 2013-10-21

Definity®

University of Louisville

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡